1998•Hämatologie und BluttransfusionRequires access

Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia

Wolfgang Kern, Carlo Aul, Georg Maschmeyer, R. Schönrock-Nabulsi, Andrea Kerkhoff, Albert Grote‐Metke, Hartmut Eimermacher, Ursula Kubica, B. Wörmann, Th. Büchner, Wolfgang Hiddemann

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mitoxantrone, Medicine, Neutropenia, Myeloid leukemia, Granulocyte colony-stimulating factor, Cytarabine, Internal medicine, Regimen

Back to paper search Browse research topics Original source

Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia — Research Paper | ScholarLens